Leukemia-associated antigens are immunogenic and have prognostic value in acute myeloid leukemia

Immunotherapy. 2011 Jun;3(6):697-9. doi: 10.2217/imt.11.50.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adaptor Proteins, Signal Transducing / immunology
  • Adaptor Proteins, Signal Transducing / metabolism
  • Antigens, Neoplasm / immunology*
  • Antigens, Neoplasm / metabolism
  • Apoptosis Regulatory Proteins / immunology
  • Apoptosis Regulatory Proteins / metabolism
  • Carbonic Anhydrase IX
  • Carbonic Anhydrases / immunology
  • Carbonic Anhydrases / metabolism
  • Extracellular Matrix Proteins / immunology
  • Extracellular Matrix Proteins / metabolism
  • Humans
  • Hyaluronan Receptors / immunology
  • Hyaluronan Receptors / metabolism
  • Inhibitor of Apoptosis Proteins / immunology
  • Inhibitor of Apoptosis Proteins / metabolism
  • Leukemia, Myeloid, Acute / diagnosis*
  • Leukemia, Myeloid, Acute / immunology*
  • Leukemia, Myeloid, Acute / metabolism
  • Microfilament Proteins / immunology
  • Microfilament Proteins / metabolism
  • Prognosis
  • Survival Analysis
  • Survivin
  • WT1 Proteins / immunology
  • WT1 Proteins / metabolism
  • fms-Like Tyrosine Kinase 3 / immunology
  • fms-Like Tyrosine Kinase 3 / metabolism

Substances

  • Adaptor Proteins, Signal Transducing
  • Antigens, Neoplasm
  • Apoptosis Regulatory Proteins
  • BIRC5 protein, human
  • CAB39L protein, human
  • Extracellular Matrix Proteins
  • Hyaluronan Receptors
  • Inhibitor of Apoptosis Proteins
  • Microfilament Proteins
  • PRAME protein, human
  • Ssx2ip protein, rat
  • Survivin
  • WT1 Proteins
  • hyaluronan-mediated motility receptor
  • FLT3 protein, human
  • fms-Like Tyrosine Kinase 3
  • CA9 protein, human
  • Carbonic Anhydrase IX
  • Carbonic Anhydrases